High frequency of LOH at chromosome 18q in human breast cancer: Association with high S-phase fraction and low progesterone receptor content

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 1031-1036

  Huiping, Chen ^a   Eiriksdottir, Gudny ^a   Sigurdsson, Asgeir ^a   Sigurgeirsdottir, Jenny Rut ^a   Barkardottir, Rosa Bjork ^a   Egilsson, Valgardur ^a   Ingvarsson, Sigurdur ^a  

^a LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

Breast cancer; Chromosome 18q; Clinicopathology; LOH (loss of heterozygosity); Tumor suppressor genes

Indexed keywords

DNA MARKER; ESTROGEN RECEPTOR; MICROSATELLITE DNA; PROGESTERONE RECEPTOR;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CELL CYCLE S PHASE; CHROMOSOME 13Q; CHROMOSOME 17Q; CHROMOSOME 18Q; CHROMOSOME 1P; CHROMOSOME 7P; CHROMOSOME 9Q; CLINICAL FEATURE; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PLOIDY; PRIORITY JOURNAL;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 18; FEMALE; HUMANS; LOSS OF HETEROZYGOSITY; PROGNOSIS; RECEPTORS, PROGESTERONE; S PHASE;

EID: 0031841107     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. El-Ashry D, Lippman ME: Molecular biology of breast carcinoma. World J Surg 18: 12-20, 1994.
2. McPherson K, Steel CM, Dixon JM: ABC of breast diseases. Breast cancer - epidemiology, risk factors and genetics. BMJ 309: 1003-1006, 1994.
3. Devilee P, Van Vliet M, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ: Somatic genetic changes on chromosome 18 in breast carcinomas: is the DCC gene involved? Oncogene 6: 311-315, 1991.
4. Fearon ER, Cho KR, Nigro JM, Kern SE, Simons JN, Ruppert JM, Hamilton SR, Preisinger AC, Thomas G, Kinzler KW, Vogelstein B: A genetic model for colorectal tumorigenesis. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247: 49-56, 1990.
5. Latil A, Baron JC, Cussenot O, Fournier G, Soussi T, Boccon-Gibod L, Le Duc A, Rouesse J, Lidereau R: Genetic alterations in localized cancers of the prostate: identification of a common region of deletion on the chromosome 18q. Bull Cancer 82: 589-597, 1995.
6. Milner BJ, Allan LA, Kelly KF, Cruickshank D, Hall M, Johnston A, Kitchener H, Parkin D, Haites N: Linkage studies with 17q and 18q markers in a breast/ovarian cancer family. Am J Hum Genet 52: 761-766, 1993.
7. Seizinger BR, Klinger HP, Junien C, Nakamura Y, Le Beau M, Cavenee W, Emanuel B, Ponder B, Naylor S, Mitelman F, Louise D, Menon A, Newsham I, Decker J, Kaelbling M, Henry I, von Deimling A: Report of the committee on chromosome and gene loss in human neoplasia. Cytogenet Cell Genet 58: 1080-1096, 1991.
8. Hahn SA, Schutte M, Hoque ATMS, Moskaluk CA, Costa LT da, Rozenblum E, Weinstein CL, Fisher A, Yeo CJ, Hruban RH, Kern SE: DPC4, A candidate tumor suppressor gene at human chromosome 18q21.1. Science 277: 350-353, 1996.
9. Borg A, Zhang QX, Olsson H, Wenngren E: Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis. Genes Chrom Cancer 5: 311-320, 1992.
10. Devilee P, Van Den Broek M, Kuipers-Dijkshoorn N, Kolluri R, Khan PM, Pearson PL, Cornelisse CJ: At least four different chromosomal regions are involved in loss of heterozygosity in human breast carcinoma. Genomics 5: 554-560, 1989.
11. Devilee P, Van Vliet M, Van Sloun P, Kuipers-Dijkshoorn N, Hermans J, Pearson PL, Cornelisse CJ: Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene 6: 1705-1711, 1991.
12. Kristjansson AK, Eiriksdottir G, Ragnarsson G, Sigurdsson A Gudmundsson J, Barkardottir RB, Jonasson JG, Egilsson V, Ingvarsson S: Loss of heterozygosity at chromosome 7q in human breast cancer: association with clinical variables. Anticancer Res 17: 93-98, 1997.
13. Eiriksdottir G, Sigurdsson A, Jonasson JG, Agnarsson BA, Sigurdsson H, Gudmundsson J, Bergthorsson JT, Barkardottir RB, Egilsson V, Ingvarsson S: Loss of heterozygosity on chromosome 9 in human breast cancer: correlation with clinical variables and genetic changes at other chromosome regions, Int J Cancer 64: 378-382, 1995.
14. Larsson C, Byström C, Skoog L, Rotstein S, Nordenskjöld M: Genomic alterations in human breast carcinomas. Genes Chrom Cancer 2: 191-197, 1990.
15. Lundberg C, Skoog L, Cavenee WK, Nordenskjöld M: Loss of heterozygosity in human ductal breast tumors indicates a recessive mutation on chromosome 13. Proc Nat Acad Sci 84: 2372-2376, 1987.
16. Pandis N, Jin Y, Limon J, Bardi G, Idvall I, Mandahl N, Mitelman F, Heim S: Interstitial deletion of the short arm of chromosome 3 as a primary chromosome abnormality in carcinomas of the breast. Genes Chrom Cancer 6: 151-155, 1993.
17. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y: Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51: 5794-5799, 1991.
18. Takita K, Sato T, Miyagi M, Watatani M, Akiyama F, Sakamoto G, Kasumi F, Abe R, Nakamura Y: Correlation of loss of alleles on the short arms of chromosome 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 52: 3914-3917, 1992.
19. Thompson AM, Morris RG, Wallace M, Wyllie AH, Steel CM, Carter DC: Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 68: 64-68, 1993.
20. Schenk M, Leib-Mosch C, Schenck IU, Jaenicke M, Indraccolo S, Saeger HD, Dallenbach-Hellweg G, Hehlmann R: Lower frequency of allele loss on chromosome 18q in human breast cancer than in colorectal tumors. Journal of Molecular Medicine 74: 155-159, 1996.
21. Huang TH, Yeh P, Martin MB, Straub RE, Gilliam C, Caldwell CW, Skibba JL: Allelic loss and instability on chromosome 18 microsatellites in infiltrating ductal carcinoma of the breast. Cancer Res 35: A 3404, 1994.
22. Huang TH, Yeh PL, Martin MB, Straub RE; Gilliam TC, Caldwell CW, Skibba JL: Genetic alterations of microsatellites on chromosome 18 in human breast carcinoma. Diagn Molec Pathol 4: 66-72, 1995.
23. Thiagalingam S, Lengauer C, Leach FS, Schutte M, Hahn SA, Overhauser J, Willson JKV, Markowitz S, Hamilton SR, Kern SE, Kinzler KW, Vogelstein B: Evalution of candidate tumor suppressor genes on chromosome 18 in colorectal cancers. Nature Genet 13: 343-346, 1996.
24. Eppert K, Scherer SW, Ozcelik H, Pirone, R, Hoodless P, Kim H, Tsui LC, Bapat B, Gallinger S, Andrulis IL, Thomsen GH, Wrana JL, Attisano L: MADR2 maps to 18q21 and encodes a TGF beta-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell 86: 543-552, 1996.
25. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G, Johannsson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V, Barkardottir RB: High prevalence of the 999de15 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56: 3663-3665, 1996.
26. Maniatis T, Fritsch EF, Sambrook J: Molecular cloning: A laboratory manual. Cold Spring Harbor Laboratory Press. New York, 1982.
27. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16: 1215, 1988.
28. Risinger JI, Boyd J: Dinucleotide repeat polymorphism in the hyman DCC gene at chromosome 18q21. Hum Mol Genet 1: 657, 1992.
29. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P: The 1993-94 Genethon human genetic linkage map. Nature Genet 7: 246-339, 1994.
30. Vignal A, Gyapay G, Hazan J, Nguyen S, Dupraz C, Cheron N: Nonradioactive multiplex procedure for genotyping of microsatellite markers. Methods in Molecular Genetics Vol. 1. San Diego: Academic Press Inc 211-221, 1993.
31. Ragnarsson G, Sigurdsson A, Eiriksdottir G, Barkardottir RB, Jonasson JG, Ingvarsson S: Loss of heterozygosity at chromosome 1p in human breast cancer: Association with high S-phase, reduced patient survival and deletion at other chromosomal regions. Int J Oncol 9: 731-736, 1996.
32. Eiriksdottir G, Bergthorsson JT, Sigurdsson H, Gudmundsson J, Skirnisdottir S, Egilsson V, Barkardottir RB, Ingvarsson S: Mapping of chromosome 3 alterations in human breast cancer using microsatellite PCR markers: Correlation with clinical variables, Int J Oncol 6: 369-379, 1995.
33. Bragadottir G, Eiriksdottir G, Sigurdsson A, Barkardottir RB, Gudmundsson J, Jonasson JG, Ingvarsson S: Loss of heterozygosity at chromosome 6q correlates with tumor progression and patient survival. Int J Oncol 7: 871-876, 1995.
34. Gudmundsson J, Barkardottir RB, Eiriksdottir G, Baldursson T, Arason A, Egilsson V, Ingvarsson S: Loss of heterozygosity at chromosome 11 in breast cancer: association of prognostic factors with genetic alterations. Br J Cancer 72: 696-701, 1995.
35. Skirnisdottir S, Eiriksdottir G, Baldursson T, Barkardottir RB, Egilsson V, Ingvarsson S: High frequency of allelic imbalance at chromosomal region 16q22-23 in human breast cancer: correlation with high PgR and low S-phase. Int J Cancer 64: 112-116, 1995.
36. Horstmann MA, Posl M, Scholz RB, Anderegg B, Simon P, Baumgaerfl K, Delling G, Kabisch H: Frequent reduction or loss of DCC gene expression in human osteosarcoma. Br J Cancer 75: 1309-1317, 1997.
37. Zhang J, Ding F, Wang X: Expression and loss of heterozygosity of DCC gene in human lung cancer. Chinese Medical Journal 75: 211-213, 1995.
38. Maesawa C, Tamura G, Suzuki Y, Dgasawara S, Sakata K, Kashiwaba M, Satodate R: The sequential accumulation of genetic alterations characteristic of the colorectal adenoma-carcinoma sequence does not occur between gastric adenoma and adenocarcinoma. J Pathol 176: 249-258, 1995.
39. Gao X, Honn KV, Grignon D, Sakr W, Chen YQ: Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas. Cancer Res 53: 2723-2727, 1993.
40. Uchida T, Wada C, Wang C, Egawa S, Ohtani H, Koshiba K: Genomic instability of microsatellite repeats and mutations of H-, K-, and N-ras, and p53 gene in renal cell carcinoma. Cancer Res 54: 3682-3685, 1994.
41. Frank CJ, Mcclatchey KD, Devaney KO, Carey TE: Evidence that loss of chromosome 18q is associated with tumor progression. Cancer Res 57: 824-827, 1997.
42. Grau AM, Zhang L, Wang WX, Ruan SB, Evans DB, Abhruzzese JL, Zhang W, Chiao PJ: Induction of P21 (WAF1) expression and growth inhibition by transforming growth factor beta involve the tumor suppressor gene DPC4 in human pancreatic adenocarcinoma cells. Cancer Res 57: 3929-3934, 1997.
43. de Winter JP, Roelen BA, ten Dijke P, van der Burg B, van der Eijnden-van Raaij AJ: DPC4 (SMAD4) mediates transforming growth factor-beta 1 (TGF-beta1) induced growth inhibition and transcriptional response in breast tumor cells. Oncogene 14: 1891-1899, 1997.
44. McGuire WL, Clark GM: Prognostic factors and treatment decisions in axillary-node negative breast cancer. N Engl J Med 326: 1756-1761, 1992.
45. Anderson TI, Gaustad A, Farrants GW, Nesland JM, Tweit KM, Borresen AL: Genetic alterations of tumor suppressor gene regions 3p, 11p, 13q, 17p and 17q in human breast carcinoma. Genes Chrom Cancer 4: 113-121, 1992.
46. Borg A, Zhang QZ, Aim P, Olsson H, Sellberg G: The retinoblastoma gene in breast cancer: allele loss is not correlated with loss of gene protein expression. Cancer Res 52: 3914-3917, 1992.
47. Takita KI, Sato T, Migyagi M, Watatani M, Akiyama F, Sakamoto G, Kasumi F, Abe R, Nakamura Y: Correlation of loss of alleles on the short arm of chromosome 11 and 17 with metastasis of primary breast cancer to lymph nodes. Cancer Res 52: 3914-3917, 1992.